Investment Stage

Focus Areas

About Investor

Steven Glazer is a Partner at Ventac Partners, concentrating on investments in pharmaceuticals, biotech, health IT, health and hospital services, diagnostics, and digital health, primarily at seed and Series A stages, with investment amounts typically between $100K and $5.0M. His professional background is rooted in venture capital with a strong focus on healthcare innovation across Europe. Glazer leverages his industry expertise to identify and support early-stage companies developing breakthrough solutions in the life sciences sector. He plays an active role in guiding portfolio companies through critical development phases and market expansion. His investment strategy aligns with Ventac Partners' commitment to advancing healthcare through cutting-edge technology and scientific innovation.